Published on 11 Feb 2025 on Reuters
, opens new tab drug to treat a type of rare genetic disorder, which causes tumors to grow in the tissue that covers nerves throughout the body. The oral...
Start tracking your investments with Statfolio
We recently published a list of the 10 Best Performing Healthcare Stocks So Far in 2025. In this...
These ten mid-cap stocks were the best performers in the last week. Are they in your portfolio? P...
Daniel Pichl, Chief People Officer at SpringWorks Therapeutics, Inc. (NASDAQ:SWTX), executed a...
Shares of SpringWorks Therapeutics, Inc. (Nasdaq: SWTX) climbed 2.7%, building on a previous gain...
, opens new tab drug to treat a type of rare genetic disorder, which causes tumors to grow in the...
On Monday, Germany-based Merck KGaA (OTC:MKGAF) (OTC:MKKGY) reacted to press reports and confirme...
We recently compiled a list of the 10 Firms Begin Trading Week With Impressive Gains. In this...
We recently compiled a list of the 12 NASDAQ Stocks with Biggest Upside Potential According to...
Shareholders of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) will be pleased this week, given tha...
Release Date: November 12, 2024 For the complete transcript of the earnings call, please refer to...